Skip to Main Content

A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis (CONSONANCE)

Conditions

Diseases of the Nervous System

What is the purpose of this trial?

Brief Summary:

This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sclerosis (PMS).

  • Ages
    18 years - 65 years
  • Gender
    Both
Find out more about who can participate in this trial
  • Trial with
    Genentech, Inc.
  • Start Date
    05/18/2021
  • End Date
    09/29/2023

For more information about this study, contact:

Lesa Moemeka

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Volunteer Now

Principal Investigator

  • Last Updated
    07/15/2021
  • Study HIC
    #2000024074

Contact Information

For more information about this study, including how to volunteer, contact Lesa Moemeka

Volunteer Now